Development of retinoic acid syndrome during leukopenia View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2011-12-20

AUTHORS

Katsuki Sugiyama, Noriko Usui, Nobuaki Dobashi, Shingo Yano, Yutaka Takei, Shinobu Takahara, Takeshi Saito, Keisuke Aiba

ABSTRACT

We present a case involving a 53-year-old male with acute promyelocytic leukemia who developed retinoic acid syndrome (RAS) during leukopenia. He received all-trans retinoic acid (ATRA) therapy at a dose of 90 mg/day (45 mg/m2). On day 17, his fever increased to 38.1°C. As pain developed in his left ankle on day 19, ATRA was discontinued on day 20 because of the suspicion of an adverse reaction to the therapy such as RAS. On day 28, his fever increased markedly, and respiratory distress and bilateral pleural effusion developed. Although his maximum leukocyte count during the course of the condition was low (3,800/μl), steroid pulse therapy was started on day 32. Thereafter, these symptoms improved dramatically. Based on the clinical manifestations observed and the patient’s complete response to steroid pulse therapy, RAS was considered to have developed in the present case. RAS is associated with the development of hyperleukocytosis in most patients, but a few patients with normal leukocyte counts have developed the syndrome. As RAS is a fatal complication of ATRA therapy, early diagnosis and treatment are very important. The present case emphasizes the view that when administering ATRA, RAS should be kept in mind at all times. More... »

PAGES

37-40

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s13691-011-0006-x

DOI

http://dx.doi.org/10.1007/s13691-011-0006-x

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1041027020


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Division of Clinical Oncology and Hematology, Department of Internal Medicine, The Jikei University School of Medicine, 3-25-8 Nishi-shinbashi, Minato-ku, 105-8461, Tokyo, Japan", 
          "id": "http://www.grid.ac/institutes/grid.411898.d", 
          "name": [
            "Division of Clinical Oncology and Hematology, Department of Internal Medicine, The Jikei University School of Medicine, 3-25-8 Nishi-shinbashi, Minato-ku, 105-8461, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sugiyama", 
        "givenName": "Katsuki", 
        "id": "sg:person.01165130270.06", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01165130270.06"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Clinical Oncology and Hematology, Department of Internal Medicine, The Jikei University School of Medicine, 3-25-8 Nishi-shinbashi, Minato-ku, 105-8461, Tokyo, Japan", 
          "id": "http://www.grid.ac/institutes/grid.411898.d", 
          "name": [
            "Division of Clinical Oncology and Hematology, Department of Internal Medicine, The Jikei University School of Medicine, 3-25-8 Nishi-shinbashi, Minato-ku, 105-8461, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Usui", 
        "givenName": "Noriko", 
        "id": "sg:person.01114721672.90", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01114721672.90"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Clinical Oncology and Hematology, Department of Internal Medicine, The Jikei University School of Medicine, 3-25-8 Nishi-shinbashi, Minato-ku, 105-8461, Tokyo, Japan", 
          "id": "http://www.grid.ac/institutes/grid.411898.d", 
          "name": [
            "Division of Clinical Oncology and Hematology, Department of Internal Medicine, The Jikei University School of Medicine, 3-25-8 Nishi-shinbashi, Minato-ku, 105-8461, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Dobashi", 
        "givenName": "Nobuaki", 
        "id": "sg:person.01150561646.26", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01150561646.26"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Clinical Oncology and Hematology, Department of Internal Medicine, The Jikei University School of Medicine, 3-25-8 Nishi-shinbashi, Minato-ku, 105-8461, Tokyo, Japan", 
          "id": "http://www.grid.ac/institutes/grid.411898.d", 
          "name": [
            "Division of Clinical Oncology and Hematology, Department of Internal Medicine, The Jikei University School of Medicine, 3-25-8 Nishi-shinbashi, Minato-ku, 105-8461, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Yano", 
        "givenName": "Shingo", 
        "id": "sg:person.01265010246.42", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01265010246.42"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Clinical Oncology and Hematology, Department of Internal Medicine, The Jikei University School of Medicine, 3-25-8 Nishi-shinbashi, Minato-ku, 105-8461, Tokyo, Japan", 
          "id": "http://www.grid.ac/institutes/grid.411898.d", 
          "name": [
            "Division of Clinical Oncology and Hematology, Department of Internal Medicine, The Jikei University School of Medicine, 3-25-8 Nishi-shinbashi, Minato-ku, 105-8461, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Takei", 
        "givenName": "Yutaka", 
        "id": "sg:person.0647406277.99", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0647406277.99"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Clinical Oncology and Hematology, Department of Internal Medicine, The Jikei University School of Medicine, 3-25-8 Nishi-shinbashi, Minato-ku, 105-8461, Tokyo, Japan", 
          "id": "http://www.grid.ac/institutes/grid.411898.d", 
          "name": [
            "Division of Clinical Oncology and Hematology, Department of Internal Medicine, The Jikei University School of Medicine, 3-25-8 Nishi-shinbashi, Minato-ku, 105-8461, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Takahara", 
        "givenName": "Shinobu", 
        "id": "sg:person.0670105772.95", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0670105772.95"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Clinical Oncology and Hematology, Department of Internal Medicine, The Jikei University School of Medicine, 3-25-8 Nishi-shinbashi, Minato-ku, 105-8461, Tokyo, Japan", 
          "id": "http://www.grid.ac/institutes/grid.411898.d", 
          "name": [
            "Division of Clinical Oncology and Hematology, Department of Internal Medicine, The Jikei University School of Medicine, 3-25-8 Nishi-shinbashi, Minato-ku, 105-8461, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Saito", 
        "givenName": "Takeshi", 
        "id": "sg:person.015754574322.05", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015754574322.05"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Clinical Oncology and Hematology, Department of Internal Medicine, The Jikei University School of Medicine, 3-25-8 Nishi-shinbashi, Minato-ku, 105-8461, Tokyo, Japan", 
          "id": "http://www.grid.ac/institutes/grid.411898.d", 
          "name": [
            "Division of Clinical Oncology and Hematology, Department of Internal Medicine, The Jikei University School of Medicine, 3-25-8 Nishi-shinbashi, Minato-ku, 105-8461, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Aiba", 
        "givenName": "Keisuke", 
        "id": "sg:person.0656467117.84", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0656467117.84"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.2165/00002018-199818040-00003", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052746756", 
          "https://doi.org/10.2165/00002018-199818040-00003"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.leu.2403031", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000323746", 
          "https://doi.org/10.1038/sj.leu.2403031"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.leu.2402807", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003885458", 
          "https://doi.org/10.1038/sj.leu.2402807"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2011-12-20", 
    "datePublishedReg": "2011-12-20", 
    "description": "We present a case involving a 53-year-old male with acute promyelocytic leukemia who developed retinoic acid syndrome (RAS) during leukopenia. He received all-trans retinoic acid (ATRA) therapy at a dose of 90\u00a0mg/day (45\u00a0mg/m2). On day\u00a017, his fever increased to 38.1\u00b0C. As pain developed in his left ankle on day\u00a019, ATRA was discontinued on day\u00a020 because of the suspicion of an adverse reaction to the therapy such as RAS. On day\u00a028, his fever increased markedly, and respiratory distress and bilateral pleural effusion developed. Although his maximum leukocyte count during the course of the condition was low (3,800/\u03bcl), steroid pulse therapy was started on day\u00a032. Thereafter, these symptoms improved dramatically. Based on the clinical manifestations observed and the patient\u2019s complete response to steroid pulse therapy, RAS was considered to have developed in the present case. RAS is associated with the development of hyperleukocytosis in most patients, but a few patients with normal leukocyte counts have developed the syndrome. As RAS is a fatal complication of ATRA therapy, early diagnosis and treatment are very important. The present case emphasizes the view that when administering ATRA, RAS should be kept in mind at all times.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s13691-011-0006-x", 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1136680", 
        "issn": [
          "2192-3183"
        ], 
        "name": "International Cancer Conference Journal", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "1"
      }
    ], 
    "keywords": [
      "retinoic acid syndrome", 
      "pulse therapy", 
      "complete response", 
      "leukocyte count", 
      "trans retinoic acid (ATRA) therapy", 
      "bilateral pleural effusion", 
      "maximum leukocyte count", 
      "steroid pulse therapy", 
      "patients complete response", 
      "normal leukocyte count", 
      "retinoic acid therapy", 
      "present case", 
      "acute promyelocytic leukemia", 
      "most patients", 
      "fatal complication", 
      "ATRA therapy", 
      "acid therapy", 
      "respiratory distress", 
      "pleural effusion", 
      "clinical manifestations", 
      "left ankle", 
      "adverse reactions", 
      "early diagnosis", 
      "promyelocytic leukemia", 
      "therapy", 
      "syndrome", 
      "leukopenia", 
      "patients", 
      "fever", 
      "days", 
      "ATRA", 
      "count", 
      "hyperleukocytosis", 
      "pain", 
      "complications", 
      "effusion", 
      "leukemia", 
      "symptoms", 
      "ankle", 
      "suspicion", 
      "diagnosis", 
      "dose", 
      "cases", 
      "manifestations", 
      "treatment", 
      "distress", 
      "males", 
      "course", 
      "response", 
      "development", 
      "time", 
      "reaction", 
      "conditions", 
      "mind", 
      "view"
    ], 
    "name": "Development of retinoic acid syndrome during leukopenia", 
    "pagination": "37-40", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1041027020"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s13691-011-0006-x"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s13691-011-0006-x", 
      "https://app.dimensions.ai/details/publication/pub.1041027020"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-08-04T17:00", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220804/entities/gbq_results/article/article_540.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s13691-011-0006-x"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s13691-011-0006-x'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s13691-011-0006-x'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s13691-011-0006-x'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s13691-011-0006-x'


 

This table displays all metadata directly associated to this object as RDF triples.

172 TRIPLES      21 PREDICATES      82 URIs      71 LITERALS      6 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s13691-011-0006-x schema:about anzsrc-for:11
2 anzsrc-for:1103
3 schema:author N4f3c1b8a4daf4739a22ff1509859e5dd
4 schema:citation sg:pub.10.1038/sj.leu.2402807
5 sg:pub.10.1038/sj.leu.2403031
6 sg:pub.10.2165/00002018-199818040-00003
7 schema:datePublished 2011-12-20
8 schema:datePublishedReg 2011-12-20
9 schema:description We present a case involving a 53-year-old male with acute promyelocytic leukemia who developed retinoic acid syndrome (RAS) during leukopenia. He received all-trans retinoic acid (ATRA) therapy at a dose of 90 mg/day (45 mg/m2). On day 17, his fever increased to 38.1°C. As pain developed in his left ankle on day 19, ATRA was discontinued on day 20 because of the suspicion of an adverse reaction to the therapy such as RAS. On day 28, his fever increased markedly, and respiratory distress and bilateral pleural effusion developed. Although his maximum leukocyte count during the course of the condition was low (3,800/μl), steroid pulse therapy was started on day 32. Thereafter, these symptoms improved dramatically. Based on the clinical manifestations observed and the patient’s complete response to steroid pulse therapy, RAS was considered to have developed in the present case. RAS is associated with the development of hyperleukocytosis in most patients, but a few patients with normal leukocyte counts have developed the syndrome. As RAS is a fatal complication of ATRA therapy, early diagnosis and treatment are very important. The present case emphasizes the view that when administering ATRA, RAS should be kept in mind at all times.
10 schema:genre article
11 schema:isAccessibleForFree true
12 schema:isPartOf N559ca2a381fa47ee8247b9c284945249
13 N790b0579166f45d3bd0464da1fb549af
14 sg:journal.1136680
15 schema:keywords ATRA
16 ATRA therapy
17 acid therapy
18 acute promyelocytic leukemia
19 adverse reactions
20 ankle
21 bilateral pleural effusion
22 cases
23 clinical manifestations
24 complete response
25 complications
26 conditions
27 count
28 course
29 days
30 development
31 diagnosis
32 distress
33 dose
34 early diagnosis
35 effusion
36 fatal complication
37 fever
38 hyperleukocytosis
39 left ankle
40 leukemia
41 leukocyte count
42 leukopenia
43 males
44 manifestations
45 maximum leukocyte count
46 mind
47 most patients
48 normal leukocyte count
49 pain
50 patients
51 patients complete response
52 pleural effusion
53 present case
54 promyelocytic leukemia
55 pulse therapy
56 reaction
57 respiratory distress
58 response
59 retinoic acid syndrome
60 retinoic acid therapy
61 steroid pulse therapy
62 suspicion
63 symptoms
64 syndrome
65 therapy
66 time
67 trans retinoic acid (ATRA) therapy
68 treatment
69 view
70 schema:name Development of retinoic acid syndrome during leukopenia
71 schema:pagination 37-40
72 schema:productId N4d2712c81aec4e83a7ef7e39a4275800
73 Nacb78fd78c0645e0b127285a5dd246bf
74 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041027020
75 https://doi.org/10.1007/s13691-011-0006-x
76 schema:sdDatePublished 2022-08-04T17:00
77 schema:sdLicense https://scigraph.springernature.com/explorer/license/
78 schema:sdPublisher N61ed34acde16465e94f38ba51f744638
79 schema:url https://doi.org/10.1007/s13691-011-0006-x
80 sgo:license sg:explorer/license/
81 sgo:sdDataset articles
82 rdf:type schema:ScholarlyArticle
83 N142196fc7c8a442b892823449d3f7e37 rdf:first sg:person.01265010246.42
84 rdf:rest N1e47d6e45e6344ee8c13b18d939aa25c
85 N1e47d6e45e6344ee8c13b18d939aa25c rdf:first sg:person.0647406277.99
86 rdf:rest Na4849708b4c5433682fc8c5cfab1ec54
87 N431b4f33c59a4836a04a9bbfb8da7d00 rdf:first sg:person.01114721672.90
88 rdf:rest N6f0d1c4c447e4dd19f9641b5e31f0caa
89 N4d2712c81aec4e83a7ef7e39a4275800 schema:name dimensions_id
90 schema:value pub.1041027020
91 rdf:type schema:PropertyValue
92 N4f3c1b8a4daf4739a22ff1509859e5dd rdf:first sg:person.01165130270.06
93 rdf:rest N431b4f33c59a4836a04a9bbfb8da7d00
94 N559ca2a381fa47ee8247b9c284945249 schema:issueNumber 1
95 rdf:type schema:PublicationIssue
96 N61ed34acde16465e94f38ba51f744638 schema:name Springer Nature - SN SciGraph project
97 rdf:type schema:Organization
98 N6f0d1c4c447e4dd19f9641b5e31f0caa rdf:first sg:person.01150561646.26
99 rdf:rest N142196fc7c8a442b892823449d3f7e37
100 N790b0579166f45d3bd0464da1fb549af schema:volumeNumber 1
101 rdf:type schema:PublicationVolume
102 N8b1fe63ba4224a0399f76219908feb35 rdf:first sg:person.0656467117.84
103 rdf:rest rdf:nil
104 Na4849708b4c5433682fc8c5cfab1ec54 rdf:first sg:person.0670105772.95
105 rdf:rest Nf497ae1c87c34c62b3e9a86e23f8b9f0
106 Nacb78fd78c0645e0b127285a5dd246bf schema:name doi
107 schema:value 10.1007/s13691-011-0006-x
108 rdf:type schema:PropertyValue
109 Nf497ae1c87c34c62b3e9a86e23f8b9f0 rdf:first sg:person.015754574322.05
110 rdf:rest N8b1fe63ba4224a0399f76219908feb35
111 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
112 schema:name Medical and Health Sciences
113 rdf:type schema:DefinedTerm
114 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
115 schema:name Clinical Sciences
116 rdf:type schema:DefinedTerm
117 sg:journal.1136680 schema:issn 2192-3183
118 schema:name International Cancer Conference Journal
119 schema:publisher Springer Nature
120 rdf:type schema:Periodical
121 sg:person.01114721672.90 schema:affiliation grid-institutes:grid.411898.d
122 schema:familyName Usui
123 schema:givenName Noriko
124 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01114721672.90
125 rdf:type schema:Person
126 sg:person.01150561646.26 schema:affiliation grid-institutes:grid.411898.d
127 schema:familyName Dobashi
128 schema:givenName Nobuaki
129 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01150561646.26
130 rdf:type schema:Person
131 sg:person.01165130270.06 schema:affiliation grid-institutes:grid.411898.d
132 schema:familyName Sugiyama
133 schema:givenName Katsuki
134 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01165130270.06
135 rdf:type schema:Person
136 sg:person.01265010246.42 schema:affiliation grid-institutes:grid.411898.d
137 schema:familyName Yano
138 schema:givenName Shingo
139 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01265010246.42
140 rdf:type schema:Person
141 sg:person.015754574322.05 schema:affiliation grid-institutes:grid.411898.d
142 schema:familyName Saito
143 schema:givenName Takeshi
144 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015754574322.05
145 rdf:type schema:Person
146 sg:person.0647406277.99 schema:affiliation grid-institutes:grid.411898.d
147 schema:familyName Takei
148 schema:givenName Yutaka
149 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0647406277.99
150 rdf:type schema:Person
151 sg:person.0656467117.84 schema:affiliation grid-institutes:grid.411898.d
152 schema:familyName Aiba
153 schema:givenName Keisuke
154 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0656467117.84
155 rdf:type schema:Person
156 sg:person.0670105772.95 schema:affiliation grid-institutes:grid.411898.d
157 schema:familyName Takahara
158 schema:givenName Shinobu
159 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0670105772.95
160 rdf:type schema:Person
161 sg:pub.10.1038/sj.leu.2402807 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003885458
162 https://doi.org/10.1038/sj.leu.2402807
163 rdf:type schema:CreativeWork
164 sg:pub.10.1038/sj.leu.2403031 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000323746
165 https://doi.org/10.1038/sj.leu.2403031
166 rdf:type schema:CreativeWork
167 sg:pub.10.2165/00002018-199818040-00003 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052746756
168 https://doi.org/10.2165/00002018-199818040-00003
169 rdf:type schema:CreativeWork
170 grid-institutes:grid.411898.d schema:alternateName Division of Clinical Oncology and Hematology, Department of Internal Medicine, The Jikei University School of Medicine, 3-25-8 Nishi-shinbashi, Minato-ku, 105-8461, Tokyo, Japan
171 schema:name Division of Clinical Oncology and Hematology, Department of Internal Medicine, The Jikei University School of Medicine, 3-25-8 Nishi-shinbashi, Minato-ku, 105-8461, Tokyo, Japan
172 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...